MedTrace Logo

Occupational Cancer Screening in Firefighters: A Pilot Study Within the Inova Health System

NCT06931561 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 800

Last updated 2026-02-27

No results posted yet for this study

Summary

The purpose of this study is to further understand the clinical impact and follow-up steps that may be required based on using whole-body Magnetic Resonance Imaging (MRI) or whole-body ultrasound and blood tests to detect multiple cancers in firefighters.

This study involves an investigational test (cancer blood test) that has not been approved by the U.S. Food and Drug Administration (FDA).

Whole-body MRI and whole-body ultrasound are approved by the U.S. Food and Drug Administration (FDA) to be used in the diagnosis of some cancers and is approved for adults and children who present other signs of potential disease. In this study, however, the whole-body MRI and the whole-body ultrasound are considered investigational devices because they are not yet approved for use in healthy adults with no other cancer indications.

Conditions

Interventions

PROCEDURE

Whole Body MRI

Whole body MRI

PROCEDURE

Whole Body Ultrasound

Whole Body Ultrasound

DEVICE

MCD Assay

Cancer detection blood test

OTHER

Occupational Exposure Questionnaire

Questionnaire

Sponsors & Collaborators

  • Virginia Department of Health

    collaborator OTHER_GOV

  • Inova Health Care Services

    lead OTHER

Principal Investigators

  • Stephanie Van Bebber · Inova Health System - Inova Schar Cancer

  • Rebecca Kaltman, MD · Inova Health System - Saville Cancer Screening and Prevention Center

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-11
Primary Completion
2028-09-30
Completion
2028-09-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06931561 on ClinicalTrials.gov